SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)

Eur J Cancer. 2021 May:148:121-123. doi: 10.1016/j.ejca.2021.02.003. Epub 2021 Feb 18.
No abstract available

Keywords: COVID- 19; Cancer; FITC; Immunotherapy; SARS-CoV-2 vaccines; mRNA-based vaccine.

Publication types

  • Letter
  • Practice Guideline

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Antineoplastic Agents, Immunological / therapeutic use*
  • BNT162 Vaccine
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / therapeutic use*
  • ChAdOx1 nCoV-19
  • France
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Immunotherapy, Adoptive*
  • Neoplasms / drug therapy*
  • Receptors, Chimeric Antigen
  • SARS-CoV-2

Substances

  • Antineoplastic Agents, Immunological
  • COVID-19 Vaccines
  • Immune Checkpoint Inhibitors
  • Receptors, Chimeric Antigen
  • ChAdOx1 nCoV-19
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine